CEACAM5 and laryngotracheoesophageal cleft: Further, like before, the combination of CEA, CYFRA 21-1, and ProGRP showed excellent malignancy detection capability, with a sensitivity of 97.5% and a specificity of 72.2% for identifying LC patients.